Medicare Enrolled

Dr. Ronald Aung-Din, M.D.

Neurology · Sarasota, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3501 CATTLEMEN RD, Sarasota, FL 34232
9413429477
In practice since 2006 (19 years)
NPI: 1215987912 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aung-Din from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aung-Din? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aung-Din

Dr. Ronald Aung-Din is a neurology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Aung-Din performed 1,409 Medicare services across 1,000 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aung-Din received a total of $31,619 from 76 pharmaceutical and/or device companies across 1124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aung-Din is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 24% volume in FL$ $31,619 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,409
Medicare services
Top 24% in FL for neurology
1,000
Unique beneficiaries
$171
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~74 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)509$122$192
Office visit, established patient (30-39 min)198$91$192
EEG, extended monitoring167$328$480
New patient office visit, complex (60-74 min)98$156$238
Measurement of brain wave activity (eeg), 12-26 hours with intermittent monitoring90$492$658
Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report90$124$350
Annual depression screening42$18$22
Administration of developmental test, first hour39$97$135
Measurement of brain wave activity (eeg), continuous34$192$253
Measurement of brain wave activity (eeg), 2-12 hours with intermittent monitoring34$338$650
Exam of neurobehavioral status, first hour32$70$106
Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report30$199$593
Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report24$80$621
New patient office visit (45-59 min)22$129$239
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$31,619
Total received (2018-2024)
Avg $4,517/year across 7 years
Top 11% in FL for neurology
76
Companies
1,124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$31,550 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,436
2023
$7,361
2022
$6,991
2021
$3,516
2020
$1,358
2019
$2,279
2018
$1,679

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$2,432
ABBVIE INC.
$2,116
Biogen, Inc.
$1,837
EMD Serono, Inc.
$1,255
AbbVie Inc.
$1,237
UCB, Inc.
$1,196
Novartis Pharmaceuticals Corporation
$1,037
Genentech USA, Inc.
$975
Lundbeck LLC
$962
Amgen Inc.
$895
Alexion Pharmaceuticals, Inc.
$879
Otsuka America Pharmaceutical, Inc.
$851
SK Life Science, Inc.
$812
Eisai Inc.
$768
IDORSIA PHARMACEUTICALS US INC
$671
Lilly USA, LLC
$651
CATALYST PHARMACEUTICALS, INC.
$623
Sunovion Pharmaceuticals Inc.
$599
Takeda Pharmaceuticals U.S.A., Inc.
$579
Celgene Corporation
$573
E.R. Squibb & Sons, L.L.C.
$559
Neurocrine Biosciences, Inc.
$540
Axsome Therapeutics, Inc.
$501
PFIZER INC.
$501
Biohaven Pharmaceutical Holding Company Ltd.
$492
GENZYME CORPORATION
$487
Harmony Biosciences LLC
$483
Biohaven Pharmaceuticals, Inc.
$434
JAZZ PHARMACEUTICALS INC.
$433
Corium, LLC
$416
ARGENX US, INC.
$413
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$408
Kyowa Kirin, Inc.
$400
HARMONY BIOSCIENCES LLC
$378
Sumitomo Pharma America, Inc.
$324
Merck Sharp & Dohme LLC
$296
ITI, Inc.
$287
Neurelis, Inc.
$263
Supernus Pharmaceuticals, Inc.
$224
Arbor Pharmaceuticals, Inc.
$201
EISAI INC.
$169
Alnylam Pharmaceuticals Inc.
$165
Acorda Therapeutics, Inc
$156
MITSUBISHI TANABE PHARMA AMERICA, INC.
$141
InSightec,Inc
$137
Azurity Pharmaceuticals, Inc.
$132
Abbott Laboratories
$131
TG Therapeutics, Inc.
$125
Octapharma USA, Inc.
$123
Janssen Pharmaceuticals, Inc
$109
Avanir Pharmaceuticals, Inc.
$109
BANNER LIFE SCIENCES, LLC
$108
MDD US Operations, LLC
$104
Greenwich Biosciences, Inc.
$104
Bayer HealthCare Pharmaceuticals Inc.
$99
IMPEL PHARMACEUTICALS INC.
$99
ARBOR PHARMACEUTICALS, INC.
$86
UPSHER-SMITH LABORATORIES LLC
$76
GRT US Holding, Inc.
$54
Allergan, Inc.
$47
Catalyst Pharmaceuticals, Inc.
$43
Mitsubishi Tanabe Pharma America, Inc.
$40
Egalet US Inc
$26
Merz Pharmaceuticals, LLC
$24
GE HealthCare
$23
Nevro Corp.
$23
Zyla Life Sciences
$23
Banner Life Sciences, LLC
$22
ASSERTIO THERAPEUTICS, Inc.
$21
Merck Sharp & Dohme Corporation
$19
Mallinckrodt Hospital Products Inc.
$19
Upsher-Smith Laboratories LLC
$19
Zogenix Inc.
$14
US WorldMeds, LLC
$14
Bausch Health US, LLC
$13
Neuronetics, Inc.
$13
Top 3 companies account for 20.2% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · Auvelity · Azstarys · BAFIERTAM · BELSOMRA · BRINTELLIX · BRIUMVI · Betaseron · Briviact · CAPLYTA · COMIRNATY · COPAXONE · Dayvigo · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · HORIZANT · HYQVIA · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NEUROSTAR TMS THERAPY · NOURIANZ · NUEDEXTA · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · Ponvory · QELBREE · QULIPTA · QUVIVIQ · Qelbree · Qutenza · RADICAVA · REXULTI · Radicava · Rebif · Rystiggo · SOLIRIS · SPRAVATO · SPRIX · SUNOSI · Soliris · TECFIDERA · TEPEZZA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · Vyvanse · WAKIX · Wakix · XCOPRI · XYWAV · ZEMBRACE SYMTOUCH · ZEPOSIA · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,244 per 100 Medicare services performed
Looking for a neurology in Sarasota?
Compare neurologys in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
37
Per 100K population
8.2
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aung-Din is a clinical cardiology specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Aung-Din experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Aung-Din performed 509 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aung-Din receive payments from pharmaceutical companies?
Yes. Dr. Aung-Din received a total of $31,619 from 76 companies across 1,124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aung-Din's costs compare to other neurologys in Sarasota?
Dr. Aung-Din's average Medicare payment per service is $171. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aung-Din) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →